littleBits, the award-winning company that empowers kids to be inventors, today announced the launch of its Droid Inventor Kit, which enables kids to create their own Droid. An integral part of the global launch of Disney and Lucasfilm's Force Friday II, the Droid Inventor Kit brings Droids to life, inspiring imagination and invention for kids around the world. Kids can easily create and power up their own mechanical companion using littleBits electronic Bits--along with the free Droid Inventor app--to send their creation on more than 17 special Star Wars missions, complete with authentic Droid sounds from the Star Wars films. As they unlock new capabilities and level up their Droid Inventor skills, kids can also learn how to create their own custom R2 Units and experiences, combining play with real hands-on learning.
“Today we are continuing a global inventor movement that empowers young people to participate in a story that inspires them to be creators, not just consumers of technology,” said Ayah Bdeir, founder & CEO of littleBits. “We’ve created a gender-inclusive product that celebrates kids’ own self-expression and ingenuity, while showcasing the same characteristics of imagination, grit and invention that are embodied in the Star Wars franchise.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8170651-littlebits-droid-inventor-kit-star-wars-kids-toys-stem/
A lil light youtube entertainment. Lovely song by Tracy Chapman and DJ Sammy, and two classic love stories portayed by an effective slideshow of pics and moving images.
Tired of Zombies & Vampires? Imagine a
world where Harry Potter meets Pirates of the Caribbean. Get Swords
& Sails: Legacy of the Red Lion, the new book by Author David
McAvoy. Sea monsters, daring rescues, and spectacular sword fights. If
you love pirates and love adventure, then you will love Swords &
Sails: Legacy of the Red Lion. Go to http://www.PirateNovel.com to
start your journey today. Let the Adventure Begin! (Copyright. 2012.
Mikazuki Publishing House. All Rights Reserved.)
Sixty years to the day since The Queen’s accession, John Walker & Sons, Scotch Whisky Distillers By Appointment to Her Majesty The Queen, celebrates the occasion with the bottling of Diamond Jubilee By John Walker & Sons; a specially crafted blend of rare malt and grain Scotch Whiskies distilled in and maturing since 1952, the year she acceded to the throne.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53755-johnwalker
With the July Fourth holiday fast approaching, Brookdale Senior Living and the nonprofit organization Wish of a Lifetime™ are celebrating patriotism by sharing the stories of four high-flying World War II veterans whose Wishes of taking to the skies again were fulfilled by the organizations. Granting these Wishes was a way to honor the service of these American heroes and to demonstrate that there is no age limit for taking new adventures. Since Brookdale and Wish of a Lifetime™ started their partnership in 2010, more than 80 of their Wishes have commemorated the service of Brookdale veterans across the country.
To view the multimedia release go to:
https://www.multivu.com/players/English/77221512-brookdale-wish-of-a-lifetime-wwii-veterans-fourth-of-july/
At the start of year-end reporting season, businesses can find themselves facing many questions about forms and deadlines. With the introduction of the Affordable Care Act in 2014, the waters got even muddier.
Greatland Corporation, an expert in forms and reporting, has developed a helpful outline for businesses facing reporting questions.
• If your business employs 50 or more full-time equivalent employees and is self-insured, you need to file Form 1095-C Parts I, II and III.
• If your business employs 50 or more full-time equivalent employees and you are NOT self-insured, you need to file Form 1095-C Parts I and II only.
• If you are a self-insured employer with less than 50 full-time equivalent employees, you are required to file Form 1095-B, Parts I, III and IV.
To view the multimedia release go to:
https://www.multivu.com/players/English/8218651-greatland-corporation-year-end-tax-reporting-advice/
NOAA’s Joint Polar Satellite System-1 (JPSS-1) is encapsulated inside the fairing (nose cone) of a United Launch Alliance Delta II launch vehicle ready for lift off from Space Launch Complex-2W at Vandenberg Air Force Base, California, on November 14, 2017 at 1:47 a.m., PST. JPSS-1 is a collaborative effort between NOAA and NASA.
“The JPSS-1 bus is based on our Ball Configurable Platform 2000, a proven, agile spacecraft, which has 50 years of on-orbit operations and is designed for cost-effective, remote sensing applications,” said Alex Chernushin, JPSS-1 Program Manager, Ball Aerospace. “JPSS-1 is the twelfth spacecraft built on this core architecture, including the Suomi National Polar-orbiting Partnership (Suomi NPP) spacecraft launched in 2011.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7987651-ball-aerospace-joint-polar-satellite-system-jpss-1-launch/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
